Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory and antinociceptive effects of botulinum toxin A in an experimental inflammatory human skin pain model
2004-005194-27Phase 4Completed
- Sponsor
- Department of Neurology, Medical University of Vienna
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pain and sunburn comparing Dysport (botulinum toxin A) with Placebo (2 arms). Primary endpoint: Main outcome variables. Started Feb 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
painsunburn
Beyond the preview
Go deeper on 2004-005194-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005194-27.